Barrett’s Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma-Reference-Cited by-同舟云学术

Barrett’s Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma

Published:2018 Issue:2 Volume:95 Page:81-90
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Amlashi Fatemeh G.^ORCID,Wang Xuemei,Davila Raquel E.,Maru Dipen M.,Bhutani Manoop S.,Lee Jeffrey H.,Weston Brian R.,Mizrak Kaya Dilsa,Vassilakopoulou Maria,Harada Kazuto,Blum Murphy Mariela A.,Rice David C.,Hofstetter Wayne L.,Davila Marta,Nguyen Quynh-nhu,Ajani Jaffer A.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference39 articles.

1. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al: The Global Burden of Cancer 2013. JAMA Oncol 2015; 1: 505–527.

2. Wild CP, Hardie LJ: Reflux, Barrett’s oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003; 3: 676–684.

3. Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, et al: Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol 2011; 106: 1231–1238.

4. Hage M, Siersema PD, van Dekken H, Steyerberg EW, Dees J, Kuipers EJ: Oesophageal cancer incidence and mortality in patients with long-segment Barrett’s oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol 2004; 39: 1175–1179.

5. Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ: Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010; 8: 235–244; quiz e32.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients;Alimentary Pharmacology & Therapeutics;2020-05-26